Downstream Processing Market to Grow at 16.4% CAGR to 2021

The global downstream processing market is projected to reach USD 22.03 billion by 2021 from USD 10.32 billion in 2016, at a CAGR of 16.4% from 2016 to 2021.Increasing demand for biopharmaceuticals and increasing R&D expenditure in the biopharmaceutical industry are the major factors driving the growth of the global downstream processing market.         

Click Here for Complete Report on  Downstream  Processing   Market   spread across 139 Pages, Profiling 11 Companies and Supported with 68 Tables and 40 Figures at http://www.rnrmarketresearch.com/downstream-processing-market-by-technique-separation-concentration-purification-product-chromatography-column-resin-filter-single-use-application-mab-production-end-user-contract-manufacturing-organi-st-to-2021-market-report.html .

Developing markets in Asia-Pacific such as Japan, China, India, South Korea, Taiwan, Australia, and Singapore are lucrative markets for downstream processing, rising geriatric population, growing per capita income, increasing investments in the healthcare industry by key market players, and increasing outsourcing services by various pharmaceutical companies from these countries are the major factors driving the growth of the downstream processing market in this region.

Introduction

1 Objectives of the Study

2 Market Definition

3 Limitations

4 Currency

5 Stakeholders

Research Methodology

1 Market Size Estimation

2 Market Breakdown and Data Triangulation

3 Key Data From Secondary Sources

4 Key Data From Primary Sources

5 Key Industry Insights

6 Assumptions for the Study

In this report, the downstream processing market is broadly segmented on the basis of technique, product, application, end user, and region. Based on application, the downstream processing market is classified into monoclonal antibody (mAbs) production, vaccine production, insulin production, immunoglobulin production, erythropoietin production, and other applications.

Click Here for Sample Papers of  Downstream Processing  Market  with Top Trends and Company Profile at http://www.rnrmarketresearch.com/contacts/request-sample?rname=948439 .

On the basis of technique, the market is segmented into purification, solid-liquid separation, and clarification/concentration. In 2016, the purification segment accounted for the largest share of the downstream processing market. The large share as well as the high growth of this segmentis attributed to the growing need for highly pure biopharmaceutical products.

Competitive Landscape

1 Overview

2 Comparative Assessment of Key Market Players

3 Competitive Situations and Trends

4 Product Launches

5 Acquisitions

6 Expansions

7 Collaborations

8 Other Strategies

New and innovative product launches was the dominant strategy adopted by key industry participants to increase their market share and cater to unmet needs. Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), Sartorius Stedim Biotech S.A. (France), Merck Millipore (Germany), and Danaher Corporation (U.S.)are some of the leading manufacturing companies that adopted this strategy.

Click Now for More Details on “Downstream Processing Market by Technique (Separation, Concentration, Purification), Product (Chromatography Column & Resin, Filter, Single use), Application (Mab Production), End User (Contract Manufacturing Organization) – Global Forecast to 2021” report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=948439 .

From an insight perspective, this research report focuses on various levels of analysis—industry analysis (industry trends) and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the downstream processing market; high-growth regions; and market drivers, restraints, and opportunities.

Contact:

[email protected]  / Call +1 888 391 5441

For further information and more details with intelligence needs for your business. Access to in-depth market trends helps companies to assess the market effectiveness.